Parkinson's Drugs Can Trigger Unhealthy...(eatment although total elimination of th...),Health

(Date:11/21/2009)..., "This bill provides for an unprecedented expan...care about if it is not for preserving and protect...t be defeated." Charmaine Yoest ,, WASHINGTO...ited for Life Action President and CEO Dr. Charmai... by releasing the following statement: ,, "Thi...

(Date:11/21/2009)... Association Discusses Key Provisions of Legislati...orm ,, ST. CHARLES, Ill., Nov. 21 /PRNewswire-...tives passing the landmark Affordable Health Care ... key health reform legislation forward, Congress h... health care system. Today, AARP hosted an educat...

(Date:11/21/2009)... Innovative medical apparel company l... , San Clemente, Calif. (P... breakthrough medical apparel, today announced the...ay at Medica 2009, a leading international trade f...ermany. Medelita inaugurates its men,s collection ...

(Date:11/21/2009)... New Haven Dental Group merges their ...Branford, CT. , (PRWEB) N...mprised of partners Dr. David Gibson, Dr. Dean Clo... has just merged their growing practice with that ...hen Dr. Pickman decided he wanted to retire from d...

(Date:11/20/2009)...PRINCETON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NU... Special Meeting of Shareholders will be held on M...ng is to consider approval of two special resoluti...d authorize the sale of all or substantially all o...s provided for in the asset purchase agreement dat...

...blished today in The Lancet from ABSORB, the world...ug eluting stent for the treatment of coronary art...clinically driven target lesion revascularizations...ar results for Abbott,s bioabsorbable everolimus e...

...Bill Given Hearing in,Joint Committee on Revenue, ... praised the efforts of State Senator Susan Fargo ...ch funding bill through the,Massachusetts State Se...rch Fund, which would be funded by a,percentage of...

...x: ILE ) today announced that on March 12, 2008 i... (AMEX) advising the Company that it does not,meet... forth in Part 10 of,the AMEX Company Guide., AME...t the Company,s stockholder,s equity was less than...

...es in follicular non-Hodgkin lymphoma , , ...therapy after chemotherapy is safe and effective f...NHL), according to an Italian study. , It found th...asible, well-tolerated and effective in follicular...

...arch Council,s Director of Women,s Health declared...national convention on sexually transmitted,diseas...nsive" or,contraceptive- and condom-based sex educ... Gaul., This week the Centers for Disease Control...

...n Expected in 2008, - Initial Results from JZP-6 P...New Data Provided on Pipeline and Early-Stage Deve...al Guidance Provided, PALO ALTO, Calif., March 13...eline,and provided 2008 financial guidance, for in...

(Date:11/19/2009)...Taiwan, Nov. 19 /PRNewswire-Asia/ -- ScinoPharm, a...ingredients (APIs), announced that its,Tainan faci...fication from,SafeBridge(R) Consultants, Inc. The ... proficiency in the safe handling of potent active... specific laboratories and,production areas used f...

(Date:11/19/2009)...ass., Nov. 19 Ligon Discovery, Inc...y technology to find drugs against high-value targ...d financing led by incTANK Ventures. The company w...ery campaign that will screen over 100 high-value ...TANK Ventures General Partner Christian Bailey joi...

(Date:11/19/2009)...Va., Nov. 19 Breast-Specific Gamma...een recognized and endorsed by two highly esteemed...: The Society of Breast Imaging (SBI) and the Amer... articles supporting the further application of th...etection of breast cancer. ,, "These endorsemen...

..., Switzerland, May 26 Arpida Ltd (SWX:,ARPN) toda...to the Phase II,"intravenous-to-oral" switch trial...tructure Infections (cSSSI). Enrolment remains on ...of the study is to assess the clinical efficacy of...own therapy in comparison,with a full course of in...

...roved Study Aimed at Harnessing Immune System to F...nters of,America (CTCA), a leading provider of inn...ex and advanced-stage disease, has begun accepting...rial. The Phase I/II,study, recently reviewed and ...FDA), will evaluate the safety and efficacy of the...

...t Manager (IM) is an instrument and LIS independen...bles laboratories to work more efficiently than ev...hat stands between instrument or medical devices a... gaps in functionality between the two, as a conne...

L'Anthony 40

... detecting and grading acquired color deficiency. ...ion of saturation thresholds for bluish pigment co...nces between normal and acquired vision defects. C... discriminates between congenital and acquired dys...

... a rapid field or laboratory test for the differen...mple, two-step test provides results in 10 minutes...ient outcomes. , ,Intended use: The NOW® H...ostic test for the detection of Hepatitis B surfac...